| Basal | Nabilone | Ibuprofen | Follow-up |
---|
n
| 30 | 26 | 26 | 26 |
HI | 0.95 ± 0.1 | 0.72 ± 0.3** | 0.78 ± 0.3** | 0.77 ± 0.3* |
DAI | 2.1 ± 1.4 | 0.89 ± 0.5**,∘ | 1.34 ± 0.9** | 1.44 ± 1.1** |
VAS | 7.9 ± 1.6 | 5.7 ± 1.9**,∘ | 6.6 ± 2.2** | 6.2 ± 2.4** |
LP (h) | 16.1 ± 7.1 | 8.7 ± 6.6** | 10.4 ± 7.3* | 11.1 ± 7.6** |
LDQ | 15.9 ± 6.3 | 9.2 ± 5.9**,∘ | 13.8 ± 6.6 | 11.9 ± 6.1* |
PFD | 2.1 ± 0.2 | 8.1 ± 9.3* | 6.6 ± 6.3* | 6.9 ± 6.3* |
- Both drugs showed improvements in all outcomes, but nabilone was always more effective than ibuprofen, with statistically significant differences in DAI, VAS and LDQ values
- HI Headache Index, DAI daily analgesic intake, VAS Visual Analogue Scale, LP lasting of pain, LDQ Leeds Dependence Questionnaire, PFD pain free days/month
- Paired t test * p < 0.05 and ** p < 0.01 versus basal; ∘ p < 0.05 versus ibuprofen